Sangamo Therapeutics, Inc. (SGMO)

0.4014 -0.03 (-6.65%) USD  |  NASDAQ  |  Jan 16, 16:00
0.404 0.00 (0.00%) After-Hours: 20:00
More

Sangamo Therapeutics EBITDA Margin (Quarterly)

EBITDA Margin (Quarterly) Chart

View EBITDA Margin (Quarterly) for SGMO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin Definition

View EBITDA Margin Definition
Start Trial

EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.

Read full definition.

EBITDA Margin (Quarterly) Range, Past 5 Years

View EBITDA Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (Quarterly) Benchmarks

View EBITDA Margin (Quarterly) Benchmarks
Start Trial
Arcturus Therapeutics Holdings, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade